We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$451M
AUM Growth
-$16.1M
Cap. Flow
-$29.1M
Cap. Flow %
-6.45%
Top 10 Hldgs %
36.92%
Holding
175
New
4
Increased
16
Reduced
46
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$13M
2
APTV icon
Aptiv
APTV
+$8.34M
3
JPM icon
JPMorgan Chase
JPM
+$3.81M
4
ALKS icon
Alkermes
ALKS
+$2.41M
5
V icon
Visa
V
+$2.03M

Sector Composition

Rank Sector Weight
1 Financials 23.48%
2 Technology 17.62%
3 Healthcare 14.5%
4 Energy 9.7%
5 Consumer Staples 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
76
Berkshire Hathaway Class B
BRK.B
$1.11T
$307K 0.07%
1,887
-225
-11% -$34.6K
SNY icon
77
Sanofi
SNY
$104B
$296K 0.07%
7,325
ETP
78
DELISTED
Energy Transfer Partners L.p.
ETP
$287K 0.06%
8,025
-3,500
-30% -$125K
ADP icon
79
Automatic Data Processing
ADP
$108B
$279K 0.06%
2,710
-650
-19% -$60.6K
KMB icon
80
Kimberly-Clark
KMB
$35.9B
$265K 0.06%
2,322
SNN icon
81
Smith & Nephew
SNN
$12.6B
$245K 0.05%
8,150
-8,200
-50% -$241K
RTX icon
82
RTX Corp
RTX
$302B
$240K 0.05%
3,475
-847
-20% -$56.1K
HD icon
83
Home Depot
HD
$356B
$235K 0.05%
1,750
AWR icon
84
American States Water
AWR
$3.44B
$231K 0.05%
5,080
WBA
85
DELISTED
Walgreens Boots Alliance
WBA
$224K 0.05%
2,711
-300
-10% -$24.8K
MET icon
86
MetLife
MET
$61.7B
$221K 0.05%
4,604
TEVA icon
87
Teva Pharmaceuticals
TEVA
$42.4B
$221K 0.05%
6,100
MITT.PRB
88
TPG Mortgage Investment Trust 8.00% Series B Preferred Stock
MITT.PRB
$93.7M
$190K 0.04%
8,000
GIS icon
89
General Mills
GIS
$20.1B
$182K 0.04%
2,954
-1,646
-36% -$102K
BA icon
90
Boeing
BA
$185B
$180K 0.04%
1,155
SYY icon
91
Sysco
SYY
$40.4B
$176K 0.04%
3,194
-1,412
-31% -$73.3K
WEC icon
92
WEC Energy
WEC
$34.6B
$176K 0.04%
3,000
TGT icon
93
Target
TGT
$69.5B
$149K 0.03%
2,075
SO icon
94
Southern Company
SO
$106B
$148K 0.03%
3,000
ED icon
95
Consolidated Edison
ED
$39.5B
$147K 0.03%
2,000
MO icon
96
Altria Group
MO
$109B
$140K 0.03%
2,064
NSC icon
97
Norfolk Southern
NSC
$75.1B
$140K 0.03%
1,300
PCG icon
98
PG&E
PCG
$37.7B
$134K 0.03%
2,200
DLR icon
99
Digital Realty Trust
DLR
$70.8B
$133K 0.03%
1,350
STT icon
100
State Street
STT
$51.5B
$132K 0.03%
1,700

Similar funds

Kelly Lawrence W & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Kelly Lawrence W & Associates held 175 positions worth $451M, down 3.4% from $467M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $29.1M in Q4 2016, closing 15 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Kelly Lawrence W & Associates opened a new position in Aptiv worth $8.36M.

  • Kelly Lawrence W & Associates's largest Q4 2016 buy was Aptiv: 124,175 shares worth $8.36M.
  • Kelly Lawrence W & Associates added most to Merck in Q4 2016, an estimated $13M increase.
  • Kelly Lawrence W & Associates's biggest Q4 2016 reduction was APA Corp, cutting an estimated $10.6M.
  • Kelly Lawrence W & Associates fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $10.7M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 37% of its $451M portfolio in Q4 2016.
  • Kelly Lawrence W & Associates opened 4 new positions and closed 15 in Q4 2016.
  • Kelly Lawrence W & Associates's portfolio value fell 3.4% quarter-over-quarter to $451M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.